Comprehensive, easy to read, and clinically relevant,Bradley’s Neurology in Clinical Practice provides the most up-to-date information presented by a veritable “Who’s Who” of clinical neuroscience. Its unique organization allows users to access content both by presenting symptom/sign and by specific disease entities-mirroring the way neurologists practice. A practical, straightforward style; templated organization; evidence-based references; and robust interactive content combine to make this an ideal, dynamic resource for both practicing neurologists and trainees.
New to this edition
The latest advances in clinical neurogenetics, brain perfusion techniques for cerebrovascular disease, the relationship between neurotrauma and neurodegenerative disease, management strategies for levodopa-related complications in movement disorders, progressive neuropsychiatric disorders arising from autoimmune encephalitis, and more keep you at the forefront of your field.
Reorganizedtable of contents which includes new chapters on: Brain Death, Vegetative, and Minimally Conscious States; Deep Brain Stimulation; Sexual Dysfunction in Degenerative and Spinal Cord Disorders; Sports and Performance Concussion; Effects of Drug Abuse on the Nervous System; and Mechanisms of Neurodegenerative Disorders.
Regular online updates reflect the latest information on the diagnosis and treatment of neurologic diseases based on the latest recommendations and methodologies.
Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.
Author Info
By Robert B. Daroff, MD, Professor, and Chair Emeritus; Department of Neurology; Case Western Reserve School of Medicine; University Hospitals Case Medical Center; Cleveland, OH, USA ; Joseph Jankovic, MD, Professor Neurology, Distinguished Chair in Movement Disorders, Director, Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX; John C Mazziotta, MD, PhD, Vice Chancellor of UCLA Health Sciences; Dean, David Geffen School of Medicine; CEO UCLA Health; University of California, Los Angeles; Los Angeles, CA, USA and Scott L Pomeroy, MD, PhD, Bronson Crothers Professor of Neurology; Director, Intellectual and Developmental Disabilities Research Center; Harvard Medical School; Chair, Department of Neurology; Neurologist-in-Chief; Boston Children’s Hospital; Boston, MA, USA